| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1657559 | F | Antileishmanial activity against Leishmania donovani HU3 infected in mouse assessed as inhibition of parasites in liver at 10 mg/kg/day, po treated for 5 days administered 7 days postinfection measured after 14 days post-infection | Leishmania donovani | 3 | organism-based format | Scientific Literature | ||
| 2. | ALA1657560 | F | Antileishmanial activity against Leishmania donovani HU3 infected in mouse assessed as inhibition of parasites in liver at 5 mg/kg/day, po treated for 5 days administered 7 days postinfection measured after 14 days post-infection | Leishmania donovani | 3 | organism-based format | Scientific Literature | ||
| 3. | ALA1657561 | F | Antileishmanial activity against Leishmania donovani HU3 infected in mouse assessed as inhibition of parasites in liver at 0.4 mg/kg/day, po treated for 5 days administered 7 days postinfection measured after 14 days post-infection | Leishmania donovani | 3 | organism-based format | Scientific Literature | ||
| 4. | ALA1656034 | F | Antileishmanial activity against Leishmania donovani HU3 infected in mouse assessed as inhibition of parasites in liver at 100 mg/kg/day, po treated for 5 days administered 7 days postinfection measured after 14 days | Leishmania donovani | 2 | organism-based format | Scientific Literature | ||
| 5. | ALA1656038 | F | Antimalarial activity Plasmodium berghei KBG-173 infected in Swiss(CD-1) mouse assessed as mean survival time at 2 mg/kg, po pretreated 2 days before infection | Plasmodium berghei | 2 | organism-based format | Scientific Literature | ||
| 6. | ALA1656039 | F | Antimalarial activity Plasmodium berghei KBG-173 infected in Swiss(CD-1) mouse assessed as mean survival time at 2 mg/kg, po pretreated 3 days before infection | Plasmodium berghei | 2 | organism-based format | Scientific Literature | ||
| 7. | ALA1656040 | F | Antimalarial activity Plasmodium berghei KBG-173 infected in Swiss(CD-1) mouse assessed as survival at 2 mg/kg, po treated 2 day postinfection measured on day 30 | Plasmodium berghei | 2 | organism-based format | Scientific Literature | ||
| 8. | ALA1656041 | F | Antimalarial activity Plasmodium berghei KBG-173 infected in Swiss(CD-1) mouse assessed as survival at 2 mg/kg, po treated 1 day postinfection measured on day 30 | Plasmodium berghei | 2 | organism-based format | Scientific Literature | ||
| 9. | ALA1656042 | F | Antimalarial activity Plasmodium berghei KBG-173 infected in Swiss(CD-1) mouse assessed as survival at 2 mg/kg, po treated at day of infection measured on day 30 | Plasmodium berghei | 2 | organism-based format | Scientific Literature | ||
| 10. | ALA1656044 | F | Antimalarial activity Plasmodium berghei KBG-173 infected in Swiss(CD-1) mouse assessed as survival at 2 mg/kg, po pretreated 3 days before infection measured on day 30 | Plasmodium berghei | 2 | organism-based format | Scientific Literature | ||
| 11. | ALA1656045 | F | Antimalarial activity against Plasmodium berghei KBG-173 infected in Swiss(CD-1) mouse assessed as mean survival time at 0.25 mg/kg/day, po treated for 3 days measured on day 6 | Plasmodium berghei | 3 | organism-based format | Scientific Literature | ||
| 12. | ALA1656046 | F | Antimalarial activity against Plasmodium berghei KBG-173 infected in Swiss(CD-1) mouse assessed as mean survival time at 1 mg/kg/day, po treated for 3 days measured on day 6 | Plasmodium berghei | 3 | organism-based format | Scientific Literature | ||
| 13. | ALA1656047 | F | Antimalarial activity against Plasmodium berghei KBG-173 infected in Swiss(CD-1) mouse assessed as reduction in parasitemia at 4 mg/kg/day, po treated for 3 days measured on day 6 | Plasmodium berghei | 2 | organism-based format | Scientific Literature | ||
| 14. | ALA1656048 | F | Antimalarial activity against Plasmodium berghei KBG-173 infected in Swiss(CD-1) mouse assessed as mean survival time at 0.25 mg/kg/day, po treated for 3 days | Plasmodium berghei | 3 | organism-based format | Scientific Literature | ||
| 15. | ALA1656049 | F | Antimalarial activity against Plasmodium berghei KBG-173 infected in Swiss(CD-1) mouse assessed as mean survival time at 1 mg/kg/day, po treated for 3 days | Plasmodium berghei | 3 | organism-based format | Scientific Literature | ||
| 16. | ALA1656051 | F | Antimalarial activity against Plasmodium berghei KBG-173 infected in Swiss(CD-1) mouse assessed as survival at 0.25 mg/kg/day, po treated for 3 days measured on day 34 | Plasmodium berghei | 3 | organism-based format | Scientific Literature | ||
| 17. | ALA1656054 | F | Antimalarial activity against Plasmodium berghei KBG-173 infected in Swiss(CD-1) mouse assessed as survival at 4 mg/kg/day, po treated for 3 days measured on day 34 | Plasmodium berghei | 2 | organism-based format | Scientific Literature | ||
| 18. | ALA1656055 | F | Antimicrobial activity against Pneumocystis carinii infected BALB/c mouse at 5 mg/kg/day, po after 21 days administered 4 weeks postinfection by Giemsa staining method | Pneumocystis carinii | 2 | organism-based format | Scientific Literature | ||
| 19. | ALA1656057 | F | Antimicrobial activity against Pneumocystis carinii infected BALB/c mouse at 1 mg/kg/day, po after 21 days administered 4 weeks postinfection by Giemsa staining method | Pneumocystis carinii | 2 | organism-based format | Scientific Literature | ||
| 20. | ALA1656058 | F | Antimicrobial activity against Pneumocystis carinii infected BALB/c mouse at 0.5 mg/kg/day, po after 21 days administered 4 weeks postinfection by Giemsa staining method | Pneumocystis carinii | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!